Clinical Trials Browser

Phase 2 × Uterine Neoplasms × Everolimus × Clear all

NCT00087685 2025-05-01

RAD001 in Recurrent Endometrial Cancer Patients

Phase 2 Completed

35 enrolled 6 charts

Uterine Neoplasms, Endometrial Neoplasms